WASHINGTON, Oct. 1 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Fresenius Kabi USA LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Pierluigi Antonelli, Chief Executive Officer, Fresenius Kabi USA LLC, 61346 Bad Homburg Germany

(b)(4)

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER
. . .

Click here for more information about our products